Swati Spentose Pvt. Ltd. is a leading specialist in Active Pharmaceutical Ingredients (APIs) and a manufacturer of complex molecules and polysaccharides. We are a part of 50+ year-old, V-Group, currently exporting to 70 countries worldwide. The company has received global FDA accreditations from several countries, including the USFDA, EDQM, and the FDA of Russia, China, Japan, Mexico, Brazil, the UK, Australia, and Canada. SSPL is currently negotiating with MIT, USA, to make a global impact in areas of biotechnology for disease areas where there are currently no medicines available. We currently operate five manufacturing sites, with expansion plans underway. Our flagship plant is located in Vapi, Gujarat. USDMFs have been filed for key products, and the company is in full compliance with GDUFA requirements. A Completeness Assessment has been successfully completed for Meloxicam (DMF #18837), and is pending for Lidocaine (DMF #25830) and Lidocaine Hydrochloride (DMF #25963). The company holds a CEP for Lidocaine Hydrochloride (R0-CEP 2013-103-Rev 00) and is in the process of obtaining CEPs for additional products. SWATIS's journey epitomizes its inherent DNA and pedigree as a truly global, pioneering, research-oriented company. With a vision to translate scientific advancements into marketable solutions, SSPL has demonstrated resilience in navigating complex and protracted research endeavors, spanning over two decades, to deliver its products to patients in need. The company's mission is to persist in developing and delivering innovative health solutions for patients worldwide who are afflicted by diseases that currently lack effective treatments.